Preoperative Intralesional Bevacizumab Injection in Primary Pterygium in Tunisian Patients: A Randomized Controlled Prospective Study.

Jihene Sayadi,Dhouha Gouider,Meher Henchiri,Racem Choura,Nadia Boujelbene,Imen Abbes,Sana Khochtali,Imene Zghal,Ines Malek,Moncef Khairallah,Leila Nacef

Journal of current ophthalmology（2022）

引用 0|浏览2

暂无评分

摘要

A single preoperative subconjunctival injection of bevacizumab 1 month before surgery decreases the vascularity of newly formed blood vessels and hence may reduce the recurrence rate.

查看译文

关键词

Bevacizumab,Pterygium,Recurrence,Subconjunctival injection,Vascularity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要